Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial

BACKGROUND: In this phase I/II trial, we evaluated the safety and effectiveness of pembrolizumab, with or without concurrent radiotherapy (RT), for lung and liver lesions from metastatic non-small cell lung cancer (mNSCLC). METHODS: Patients with lung or liver lesions amenable to RT plus at least on...

詳細記述

保存先:
書誌詳細
出版年:J Immunother Cancer
主要な著者: Welsh, James, Menon, Hari, Chen, Dawei, Verma, Vivek, Tang, Chad, Altan, Mehmet, Hess, Kenneth, de Groot, Patricia, Nguyen, Quynh-Nhu, Varghese, Rejani, Comeaux, Nathan I, Simon, George, Skoulidis, Ferdinandos, Chang, Joe Y, Papdimitrakopoulou, Vasiliki, Lin, Steven H, Heymach, John V
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2020
主題:
Clinical/Translational Cancer Immunotherapy
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7555111/
https://ncbi.nlm.nih.gov/pubmed/33051340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001001
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料